Prediction of myocardial ischemia–reperfusion injury post-PCI: role of sST2 levels in STEMI patients
Abstract Background Myocardial ischemia–reperfusion injury (MIRI) after ST-segment elevation myocardial infarction (STEMI) significantly impacts clinical outcomes. However, only a few studies have examined its clinical predictors and prognostic biomarkers. Methods Patients with STEMI who received pe...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Cardiovascular Disorders |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12872-025-04708-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849726230869311488 |
|---|---|
| author | Wenjing Che Yubin Jin Shumin Chang Yihan Sun Aijie Hou Chengfu Wang |
| author_facet | Wenjing Che Yubin Jin Shumin Chang Yihan Sun Aijie Hou Chengfu Wang |
| author_sort | Wenjing Che |
| collection | DOAJ |
| description | Abstract Background Myocardial ischemia–reperfusion injury (MIRI) after ST-segment elevation myocardial infarction (STEMI) significantly impacts clinical outcomes. However, only a few studies have examined its clinical predictors and prognostic biomarkers. Methods Patients with STEMI who received percutaneous coronary intervention (PCI) at Liaoning Provincial People's Hospital between 2020 and 2021 were enrolled in the study. Based on a thorough evaluation of clinical features, which included data obtained from intraoperative angiography and inpatient monitoring, patients were divided into the MIRI group and the non-MIRI group. Upon admission, serum solube growth stimulation expressed gene 2 protein (sST2) levels were assessed, and follow-up examinations were conducted for the patients. Results Patients with MIRI who were admitted to the hospital present elevated serum sST2 levels (P < 0.001). Serum sST2 was recognized as a standalone risk factor contributing to the occurrence of MIRI in STEMI patients who are undergoing PCI (P < 0.001). Throughout the follow-up duration, 37 (17.0%) patients encountered major adverse cardiovascular and cerebrovascular incidents (MACCEs), which included eight (3.6%) deaths from all causes. The Kaplan–Meier assessment revealed that individuals in the MIRI group had an unfavorable prognosis (all log-rank P < 0.05). Both univariable and multivariable Cox regression models were established using MIRI patients as the study cohort. The findings indicated that sST2 levels exceeding 68.98 ng/mL served as one of independent risk factors for predicting MACCEs (all P < 0.001). The model was evaluated using the C-index, AUC, calibration plot, and Decision Curve Analysis (DCA) curve. Conclusion Elevated levels of serum sST2 may accurately predict the onset of MIRI following PCI in STEMI patients. Specifically, a serum sST2 concentration > 68.98 ng/mL is a prominent independent risk predictor for overall mortality and MACCE in individuals experiencing MIRI. Graphical Abstract |
| format | Article |
| id | doaj-art-07eaa59c6983406b8b8f1084ec6f9c91 |
| institution | DOAJ |
| issn | 1471-2261 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Cardiovascular Disorders |
| spelling | doaj-art-07eaa59c6983406b8b8f1084ec6f9c912025-08-20T03:10:14ZengBMCBMC Cardiovascular Disorders1471-22612025-04-0125111310.1186/s12872-025-04708-6Prediction of myocardial ischemia–reperfusion injury post-PCI: role of sST2 levels in STEMI patientsWenjing Che0Yubin Jin1Shumin Chang2Yihan Sun3Aijie Hou4Chengfu Wang5Department of Cardiology, The People’S Hospital of China Medical University, the People’S Hospital of Liaoning ProvinceDepartment of Cardiology, The People’S Hospital of China Medical University, the People’S Hospital of Liaoning ProvinceDepartment of Cardiology, The People’S Hospital of China Medical University, the People’S Hospital of Liaoning ProvinceDepartment of Cardiology, The People’S Hospital of China Medical University, the People’S Hospital of Liaoning ProvinceDepartment of Cardiology, The People’S Hospital of China Medical University, the People’S Hospital of Liaoning ProvinceDepartment of Cardiology, The People’S Hospital of China Medical University, the People’S Hospital of Liaoning ProvinceAbstract Background Myocardial ischemia–reperfusion injury (MIRI) after ST-segment elevation myocardial infarction (STEMI) significantly impacts clinical outcomes. However, only a few studies have examined its clinical predictors and prognostic biomarkers. Methods Patients with STEMI who received percutaneous coronary intervention (PCI) at Liaoning Provincial People's Hospital between 2020 and 2021 were enrolled in the study. Based on a thorough evaluation of clinical features, which included data obtained from intraoperative angiography and inpatient monitoring, patients were divided into the MIRI group and the non-MIRI group. Upon admission, serum solube growth stimulation expressed gene 2 protein (sST2) levels were assessed, and follow-up examinations were conducted for the patients. Results Patients with MIRI who were admitted to the hospital present elevated serum sST2 levels (P < 0.001). Serum sST2 was recognized as a standalone risk factor contributing to the occurrence of MIRI in STEMI patients who are undergoing PCI (P < 0.001). Throughout the follow-up duration, 37 (17.0%) patients encountered major adverse cardiovascular and cerebrovascular incidents (MACCEs), which included eight (3.6%) deaths from all causes. The Kaplan–Meier assessment revealed that individuals in the MIRI group had an unfavorable prognosis (all log-rank P < 0.05). Both univariable and multivariable Cox regression models were established using MIRI patients as the study cohort. The findings indicated that sST2 levels exceeding 68.98 ng/mL served as one of independent risk factors for predicting MACCEs (all P < 0.001). The model was evaluated using the C-index, AUC, calibration plot, and Decision Curve Analysis (DCA) curve. Conclusion Elevated levels of serum sST2 may accurately predict the onset of MIRI following PCI in STEMI patients. Specifically, a serum sST2 concentration > 68.98 ng/mL is a prominent independent risk predictor for overall mortality and MACCE in individuals experiencing MIRI. Graphical Abstracthttps://doi.org/10.1186/s12872-025-04708-6Myocardial infarctionAcute ST-segment elevationSoluble growth-stimulated expressed gene 2 proteinMyocardial ischemia–reperfusion injuryReperfusion |
| spellingShingle | Wenjing Che Yubin Jin Shumin Chang Yihan Sun Aijie Hou Chengfu Wang Prediction of myocardial ischemia–reperfusion injury post-PCI: role of sST2 levels in STEMI patients BMC Cardiovascular Disorders Myocardial infarction Acute ST-segment elevation Soluble growth-stimulated expressed gene 2 protein Myocardial ischemia–reperfusion injury Reperfusion |
| title | Prediction of myocardial ischemia–reperfusion injury post-PCI: role of sST2 levels in STEMI patients |
| title_full | Prediction of myocardial ischemia–reperfusion injury post-PCI: role of sST2 levels in STEMI patients |
| title_fullStr | Prediction of myocardial ischemia–reperfusion injury post-PCI: role of sST2 levels in STEMI patients |
| title_full_unstemmed | Prediction of myocardial ischemia–reperfusion injury post-PCI: role of sST2 levels in STEMI patients |
| title_short | Prediction of myocardial ischemia–reperfusion injury post-PCI: role of sST2 levels in STEMI patients |
| title_sort | prediction of myocardial ischemia reperfusion injury post pci role of sst2 levels in stemi patients |
| topic | Myocardial infarction Acute ST-segment elevation Soluble growth-stimulated expressed gene 2 protein Myocardial ischemia–reperfusion injury Reperfusion |
| url | https://doi.org/10.1186/s12872-025-04708-6 |
| work_keys_str_mv | AT wenjingche predictionofmyocardialischemiareperfusioninjurypostpciroleofsst2levelsinstemipatients AT yubinjin predictionofmyocardialischemiareperfusioninjurypostpciroleofsst2levelsinstemipatients AT shuminchang predictionofmyocardialischemiareperfusioninjurypostpciroleofsst2levelsinstemipatients AT yihansun predictionofmyocardialischemiareperfusioninjurypostpciroleofsst2levelsinstemipatients AT aijiehou predictionofmyocardialischemiareperfusioninjurypostpciroleofsst2levelsinstemipatients AT chengfuwang predictionofmyocardialischemiareperfusioninjurypostpciroleofsst2levelsinstemipatients |